Tag: CA4P

April 20, 2017

Mateon Through Partner Begins Phase 1 Study of CA4P

Mateon Therapeutics announced the start of an investigator-sponsored Phase 1 study CA4P in combination with everolimus for the treatment of...
April 18, 2017

Mateon Shows Results from Interim Analysis of FOCUS Study

Mateon Therapeutics announced a set of interim data from its ongoing Phase 2/3 study in patients with platinum-resistant ovarian cancer...
March 30, 2017

Mateon Releases Financial Results For 2016

Mateon Therapeutics (OTCQX: MATN) posted its financial results for 2016 and gave out an update on the company and its...